Immunodiagnostic Systems Holdings Plc (IDH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2005 | 03-2004 | 03-2003 | 03-2002 | |
| Cash Flows From Operating Activities | ||||
| Accounts receivable | -146 | -145 | -46 | -96 |
| Other Working Capital | -796 | 55 | 158 | -258 |
| Other Operating Activity | 644 | 305 | 412 | 637 |
| Operating Cash Flow | $-298 | $215 | $524 | $283 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -117 | -419 | -131 | -64 |
| Net Acquisitions | -761 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -198 | N/A | -204 |
| Investing Cash Flow | $-878 | $-617 | $-131 | $-268 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 625 | 278 | N/A | N/A |
| Debt Repayment | -88 | -29 | N/A | -26 |
| Common Stock Issued | 1,036 | N/A | N/A | N/A |
| Other Financing Activity | -41 | -29 | -153 | -306 |
| Financing Cash Flow | $1,532 | $220 | $-153 | $-332 |
| Beginning Cash Position | -218 | 224 | 31 | 348 |
| End Cash Position | -357 | -217 | 271 | 31 |
| Net Cash Flow | $356 | $-182 | $240 | $-317 |
| Free Cash Flow | ||||
| Operating Cash Flow | -298 | 215 | 524 | 283 |
| Capital Expenditure | -123 | -609 | -148 | -64 |
| Free Cash Flow | -421 | -394 | 376 | 219 |